NSEDCP
BIVV

NJ State Employees Deferred Compensation Plan’s Bioverativ Inc. Common Stock BIVV Stock Holding History

NJ State Employees Deferred Compensation Plan’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-11,000
Closed -$593K – 501
2017
Q4 		$593K Buy
+11,000
New +$602K 0.1% 295

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's BIVV Position: Q1 2018 in Review

NJ State Employees Deferred Compensation Plan sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 11,000 shares — an estimated $593K sold.

NJ State Employees Deferred Compensation Plan first reported a position in BIVV in Q4 2017 and held it in 1 quarter. The position peaked at $593K in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • NJ State Employees Deferred Compensation Plan reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • NJ State Employees Deferred Compensation Plan sold 11,000 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $593K.
  • NJ State Employees Deferred Compensation Plan first reported a position in Bioverativ Inc. Common Stock in Q4 2017 and held it in 1 quarter.
  • NJ State Employees Deferred Compensation Plan's Bioverativ Inc. Common Stock position peaked at $593K in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q1 2018, filed 2 May 2018.